Biomedical Engineering Reference
In-Depth Information
9. Friedman, E., Fung, F., and Gershon, S. (1977) Antidepressant drugs and dopamine
uptake in different brain regions.
Eur. J. Pharmacol.
42,
47-51.
10. Randrup, A. and Braestrup, C. (1977) Uptake inhibition of biogenic amines by
newer antidepressant drugs: relevance to the dopamine hypothesis of depression.
Psychopharmacology (Berl.)
53,
309-314.
11. Petrali, E. H. (1980) Differential effects of benztropine and desipramine on
the high affi nity uptake of paratyramine in slices of the caudate nucleus and
hypothalamus.
Neurochem. Res.
5,
297-300.
12. Holmes, J. C. and Rutledge, C. O. (1976) Effects of the
d
- and
l
-isomers of
amphetamine on uptake, release and catabolism of norepinephrine, dopamine
and 5-hydroxytryptamine in several regions of rat brain.
Biochem. Pharmacol.
25,
447-451.
13. Hadfi eld, M. G. and Nugent, E. A. (1983) Cocaine: comparative effect on dopamine
uptake in extrapyramidal and limbic systems.
Biochem. Pharmacol.
32,
744-746.
14. Howell, L. L. and Wilcox, K. M. (2001) The dopamine transporter and
cocaine medication development: drug self-administration in nonhuman primates.
J. Pharmacol. Exp. Ther.
298,
1-6.
15. Laakso, A. and Hietala, J. (2000) PET studies of brain monoamine transporters.
Curr. Pharm. Des.
6,
1611-1623.
16. Prochiantz, A., Di Porzio, U., Kato, A., Berger, B., and Glowinski, J. (1979) In
vitro maturation of mesencephalic dopaminergic neurons from mouse embryos
is enhanced in presence of their striatal target cells.
Proc. Natl. Acad. Sci. USA
76,
5387-5391.
17. Lau, Y. S., Hao, R., Fung, Y. K., et al. (1998) Modulation of nigrostriatal dopa-
minergic transmission by antisense oligodeoxynucleotide against brain-derived
neurotrophic factor.
Neurochem. Res.
23,
525-532.
18. Lau, Y. S., Fung, Y. K., Trobough, K. L., Cashman, J. R., and Wilson, J. A.
(1991) Depletion of striatal dopamine by the N-oxide of 1-methyl-4-phenyl-1,2,3,
6-tetrahydropyridine (MPTP).
Neurotoxicology
12,
189-199.
Search WWH ::
Custom Search